Differences in clinical severity between genotype A and genotype B human metapneumovirus infection in children
Diego Vicente1, Milagrosa Montes, Gustavo Cilla
1Servicio de Microbiologia, Hospital Donostia, Spain.
Abstract:
The clinical spectrum of 69 episodes of metapneumovirus pediatric infection (55 episodes caused by genotype A and 14 episodes caused by genotype B) was analyzed. Diagnosis of pneumonia was more common and the illness severity index (determined on the basis of need for hospitalization, oxygen saturation <90%, and intensive care unit stay) was higher for patients with metapneumovirus genotype A infection.
Insights
Human metapneumovirus (hMPV) genotype A infections in children are linked to more severe illness, including higher rates of pneumonia and hospitalization, compared to genotype B. This highlights key differences in clinical presentation between hMPV strains.
Area of Science:
- Pediatric Infectious Diseases
- Virology
- Respiratory Infections
Background:
- Human metapneumovirus (hMPV) is a significant respiratory pathogen in children.
- Two main genotypes, A and B, circulate and may differ in clinical impact.
Purpose of the Study:
- To analyze and compare the clinical spectrum of pediatric hMPV infections caused by genotypes A and B.
- To identify potential differences in disease severity between hMPV genotypes.
Main Methods:
- Retrospective analysis of 69 pediatric hMPV infection episodes.
- Categorization of infections by genotype (55 genotype A, 14 genotype B).
- Assessment of clinical outcomes including pneumonia diagnosis and an illness severity index (hospitalization, oxygen saturation, ICU stay).
Main Results:
- Pneumonia diagnosis was more frequent in children infected with hMPV genotype A.
- The illness severity index was significantly higher for genotype A infections.
- Patients with genotype A required hospitalization and intensive care unit (ICU) more often.
Conclusions:
- hMPV genotype A is associated with more severe clinical outcomes in pediatric patients compared to genotype B.
- Genotype-specific differences in hMPV clinical presentation warrant further investigation.
- Understanding these differences can inform clinical management and public health strategies.
Related Concept Videos
01:29Respiratory Syncytial Virus Disease
Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
01:29Malaria
Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
01:18Viral Meningitis
Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
01:14Atypical Pneumonia
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
01:27Cytomegalovirus Disease
Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...